VIVOS INC
For the period ended Dec 31, 2023. Filed Mar 18, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 18, 2024
RDGLStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2023 and 2022
BALANCE SHEETS
DECEMBER 31, 2023 AND 2022
| DECEMBER 31, 2023 | DECEMBER 31, 2022 | |
|---|---|---|
| ASSETS | ||
| Current Assets: | ||
| Cash | $1,592,287 | $1,706,065 |
| Accounts receivable | 7,000 | 11,000 |
| Prepaid expense | 10,837 | 25,671 |
| Total Current Assets | 1,610,124 | 1,742,736 |
| TOTAL ASSETS | $1,610,124 | $1,742,736 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| LIABILITIES | ||
| Current Liabilities: | ||
| Accounts payable and accrued expense | $245,004 | $81,692 |
| Total Current Liabilities | 245,004 | 81,692 |
| Total Liabilities | 245,004 | 81,692 |
| Commitments and contingencies | - | - |
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock, par value, $0.001, 20,000,000 shares authorized, Series A Convertible Preferred, 5,000,000 shares authorized, 2,071,007 shares issued and outstanding, respectively | 2,071 | 2,071 |
| Additional paid in capital - Series A Convertible preferred stock | 8,842,458 | 8,842,458 |
| Series B Convertible Preferred, 5,000,000 shares authorized, 200,363 shares issued and outstanding, respectively | 200 | 200 |
| Additional paid in capital - Series B Convertible preferred stock | 290,956 | 290,956 |
| Series C Convertible Preferred, 5,000,000 shares authorized, 385,302 shares issued and outstanding, respectively | 385 | 385 |
| Additional paid in capital - Series C Convertible preferred stock | 500,507 | 500,507 |
| Common stock, par value, $0.001, 950,000,000 shares authorized, 387,894,033 and 362,541,528 issued and outstanding, respectively | 387,894 | 362,541 |
| Additional paid in capital - common stock | 73,791,430 | 71,217,954 |
| Accumulated deficit | (82,450,781) | (79,556,028) |
| Total Stockholders’ Equity | 1,365,120 | 1,661,044 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $1,610,124 | $1,742,736 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.